Advisory Board

Arseniy Dabbakh

Director, Corporate Finance, Rye, Man & Gor securities, Moscow
Biography

Education:
MBA, California State University Hayward
Moscow University of Peoples Friendship (civil law)
Professional experience:
2010until present
Rye, Man & Gor Securities, an investment firm
Director, corporate finance
20052010
Gurus Capital, investment consulting
Founder, Managing Partner
Prior to 2005
3M, Digitex Europe, Ergodata and other companies
Department manager for marketing and business development
Experience:
Participation in consulting and M&A projects, business evaluation, due diligence and strategic consulting. Coordination of programs by Russian and overseas clients, including Sanofi Aventis, Amer Sports, Cementir Holding, Continent Logistics and others.
Key competencies: strategic analysis and planning; business evaluation; market analysis; financial modeling and development strategies
Areas of interests: M&A transactions; corporate development strategies; increase in corporate valuation; due diligence; corporate and investment project evaluation; PE finance raising; investment banking; PE funds; VC capital; business angel associations; synergies in M&A transactions; business alliances and JVs; deals structuring
Personal publications and media references to / comments by the expert


Contributes articles for business journals, runs A.D. Dabbakh blogs at http://slon.ru/blogs/adabbakh/ and Vedomosti media.
 

Feature stories

17 May '17
Russian biologists and biophysicists are said to have...
21 Apr '17
6 Mar '17
Developing a photonic computer, a technology that...
Search (News archive - 21088)
Advertising
RB_Partners_Venture_Report2016
Advertising
Why Russians do not smile
Advertising
Nano & Giga Symposium
Advertising
UNN

Latest News

29 May '17
An intelligent cardiovascular diseases diagnostics...
27 May '17
Russia rose in a global ranking that assesses...
25 May '17
Russian scientists in partnership with their Korean...

Most read stories from last week

27 May '17
Russia rose in a global ranking that assesses...
29 May '17
An intelligent cardiovascular diseases diagnostics...